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ABSTRACT

Insulin Dynamic Measures and Weight Change

By

Noreen Kloc
B.S. Computer Information Technology, Purdue University

December 7, 2015

INTRODUCTION: Weight gain and obesity are risk factors for insulin resistance that can lead to type 2
diabetes and cardiovascular disease; however, there is a complicated interplay between insulin
sensitivity (S I ), fasting insulin, acute insulin response (AIR), and disposition index (DI) and the
relationship of these dynamic measures with weight change is not well understood.

AIM: The aim of this study was to investigate the relationships between insulin dynamic measures, S I ,
fasting insulin, AIR, and DI, with weight change during a 5-years follow-up period in the multi-ethnic
cohort of the Insulin Resistance Atherosclerosis Study (IRAS).

METHODS: Data on 879 men and women of Hispanic, non-Hispanic White, and African-American
race/ethnicity aged 40-69 years were obtained at baseline (1992-1994) and at 5 year follow-up. Crude
associations between the insulin dynamic measures and weight change were evaluated using KruskalWallis test and the relationships between log-transformed insulin-related variables were examined using
Spearman rank-order analysis. Multivariate regression models evaluated associations of interest
adjusted for age, sex, ethnicity, and diabetes status in a time-dependent manner using mixed models.

RESULTS: Insulin sensitivity S I inversely coevolves with weight, i.e. greater weight is predicted by lower
S I at any time point. To answer the question whether S I is the cause or a consequence of weight change,
we examined the associations with the baseline values and a change in S I . In this model, both the
baseline S I and change in S I were inversely correlated with weight gain. A similar approach showed that
baseline values and change in fasting insulin were directly associated with weight gain. Weight change
over time was associated with AIR, i.e. increases in AIR and greater AIR at baseline predicted weight
gain. We did not find strong relationships between DI and weight change.

DISCUSSION: These results suggest that insulin sensitivity and insulin secretion can modulate weight in
a non-diabetic population.
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Insulin Dynamic Measures and Weight Change

I. Introduction
Weight gain and obesity are risk factors for insulin resistance that can lead to type 2 diabetes
and cardiovascular disease (CVD) (1). Physiologically, insulin is a hormone produced in the
pancreas and moves into the blood helping glucose to be incorporated into cells. Muscle, fat
and liver cells absorb glucose from the bloodstream which then lowers blood glucose levels.
Insulin stimulates the liver and muscle tissue to incorporate the excess glucose. Insulin
resistance is a syndrome in which insulin is produced but not used effectively causing the
glucose to build up in the blood leading to impaired glucose status or type 2 diabetes (2). Other
clinical diseases associated with insulin resistance syndrome are CVD, hypertension, polycystic
ovary syndrome, nonalcoholic liver disease, sleep apnea, several types of cancer (3) and may be
a risk for coronary heart disease and stroke (4).
There is a complicated interplay between weight gain, insulin sensitivity, and insulin secretion.
Weight gain leads to a drop in insulin sensitivity (increase in insulin resistance). In non-diabetic
individuals, change in insulin sensitivity is often compensated by an increase in insulin secretion
and fasting insulin. Such compensation can produce a metabolic environment that promotes
further weight gain. Insulin is known to promote weight gain in diabetic patients who take
insulin as a part of their regimen. Thus, not only does weight gain promote insulin resistance
but a compensatory increase in insulin can stimulate further weight increase, creating a vicious
cycle. The aim of this study was to investigate how the insulin dynamic factors, insulin
sensitivity (S I ), fasting insulin, acute insulin response (AIR), and disposition index (DI) influence
weight change during a 5-year period in a cohort of 879 triethnic participants.
II. Review of the Literature
Research into insulin dynamics and weight change has been conducted for several decades;
however the relationship is complicated. A higher S I value expresses insulin sensitivity as a
measure of insulin-stimulated glucose disposal. This is an inverse measure of insulin resistance.
Another index of insulin resistance is higher fasting insulin. A higher AIR implies greater insulin
secretion in response to glucose, which might be greater when insulin action is diminished. A
product of S I and AIR, DI offsets the influence of insulin resistance on AIR and is accepted as an
index of pancreatic function (5).
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The beneficial effect of weight loss on glucose tolerance has been documented in many
research studies (6-9). However, the relationship of glucose regulation to changes in weight is
not clear with studies documenting varying results. Early studies suggested insulin resistance
may cause weight gain due to reduced thermic effects (10), increased appetite (11), or a genetic
artifact for increased fat storage (12); but later studies have suggested insulin resistance might
increase fat oxidation (13), or serve as a homeostatic mechanism protecting against weight gain
(14, 15). A large population study showed that people who have been diagnosed with diabetes
tend to not gain weight or lose excess weight (16). These studies provided weak evidence since
biological tests and relevant confounders were not included.
The results of studies using clinical measures differ in their results due to different measures of
insulin dynamics and weight, varying lengths of follow-up, and controlling for different
confounders. Animal and human studies suggest that insulin dynamics including insulin
sensitivity and insulin secretion are associated with weight change but the direction of that
change (negative or positive) is inconsistent with different studies (17, 18). Age, sex,
race/ethnicity, diabetic status, BMI, energy expenditure, smoking status, alcohol consumption
and length of follow-up varied in study population parameters and the length of follow-up.
The studies examining the relationship of poor insulin dynamics and wait gain found that higher
levels of fasting insulin at baseline predict visceral fat (19) or weight change (20, 21) during the
follow-up. These studies did not include age or initial weight in the analysis, only non-diabetic
adults were included, one study controlled for lifestyle variables (i.e. physical activity and diet
fat intake), and the study follow-up period differed between 3 and 10 years.
Other studies documented a positive association of insulin dynamic measures to changes in
weight with average plasma glucose predicting more weight gain (22-24) or higher insulin
resistance at baseline predicted weight loss or no weight change during follow-up (15, 24-27).
The studies that controlled for demographic variables included age, sex and race/ethnicity, four
controlled for medication (22, 24, 26, 27) and some controlled for lifestyle behavior (15, 22, 27).
The finding of these studies was that poor glucose was associated with lower weight gain but
did not vary with age, initial weight, sex, and race/ethnicity while two studies found that insulin
resistance and less weight gain were greater in participants not using insulin (24, 26).
Studies that documented complex relationships between glucose regulation and changes in
weight suggest that age, sex, race/ethnicity, baseline weight, and specific measures of weight
can affect the results. A five year longitudinal study controlling for age and BMI found results
differed by race/ethnicity (28). In Chinese men, weight gain was predicted by insulin resistance
which differed in Asian Indian and Creole adults where weight gain was predicted by better
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insulin sensitivity. In addition, only body weight was associated with insulin resistance and no
relationship was found in waist to hip ratio (28).
In reviewing the findings of the existing studies, the aim of this current study was to utilize a
large study population of diverse race/ethnicity and demographic parameters, include relevant
biological measures and control for relevant confounders including BMI, sex, age, and diabetes
status.
III. Methods and Procedures
The Insulin Resistance Atherosclerosis Study (IRAS) was designed to assess the relation of
insulin and insulin resistance to cardiovascular disease and its risk factors. Details of the IRAS
study design have been previously published (29). The study protocols were approved by the
institutional review boards of each clinical center located in Oakland, California; Los Angeles,
California; San Antonio, Texas; and the San Luis Valley, Colorado (29). All participants provided
written informed consent.
Sample Selection
The study recruited 1624 male and female participants aged 40 – 69 years from four geographic
areas representing three ethnic groups (Hispanic, non-Hispanic white, and African-American) in
1992-1994. A follow-up period of approximately 5 years occurred between 1997 and 1998.
Participants with existing diabetes status, missing weight at baseline or missing weight at
follow-up were eliminated from the study population (n=730). Diabetic patients exhibit shifting
insulin dynamics and insulin secretion in response to weight which differs between diabetics
and non-diabetics and these patients often intentionally try to lose weight (1, 18). An additional
four participants were eliminated due to a mismatch in weight and waist circumference and
one participant with duplicate ID was removed. Eleven more participants with missing relevant
data were eliminated with a final study population of 879.
Variable Measurement
During the first visit at each time point, a 75-g oral glucose tolerance test (OGTT) was used to
assess glucose tolerance status based on the World Health Organization (WHO) criteria (30) and
to determine fasting insulin concentration (26). The WHO diabetes status criteria using the
OGTT : normal < 140 mg/dl, impaired 140 – 199 mg/dl, and diabetic ≥ 200 mg/dl (30). During
the second visit at east time point, insulin sensitivity and first-phase insulin secretion were
measured by FSIGTT with minimal model analysis (31). Insulin resistance, expressed as the
Insulin Sensitivity Index (S I ) was calculated using mathematical modeling methods (MINMOD,
version 3.0, Los Angeles, California, courtesy of Richard Bergman, PhD) (32). To assess
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sensitivity of β–cell function, insulin secretion was measured by the AIR variable as the mean of
plasma concentration from 2- and 4-minute time points after glucose administration (26).
Disposition Index (DI) is an alternate insulin secretion variable based on the hyperbolic relation
of insulin secretion to S I and expresses the ability of the pancreatic β–cell to compensate for
changes in S I by increasing insulin secretion (33, 34). DI was calculated as the product of S I and
AIR. BMI was calculated as weight in kilograms divided by height in meters squared.
Race/Ethnicity and other demographic data were assessed by self-report. Anthropometric
measurements were obtained by trained personnel.
Statistical Analysis
All statistical analysis was performed using SAS statistical software (version 9.3, SAS Institute,
Cary, NC). In multivariate correlations and regression models, log-transformed values of fasting
insulin, AIR, S I and DI were used to minimize the influence of extreme observations. Some
individuals had an S I value of zero so the natural logarithm of S I was added to the contant 1 was
used for transformation. DI was calculated as the sum of log-transformed S I + 1 and logtransformed AIR. A weight change status variable grouped the difference in weight between
baseline and follow-up into Increased Weight (≥5%), No Weight Change (<>5%) and Decreased
Weight (≤5%).
The crude associations of weight change status and covariates were examined using chi-square
test for the ordinal and categorical variables, and Kurskal-Wallis for all continuous variables
including the main exposure variables S I , Fasting Insulin, AIR and DI. Crude associations of the
log-transformed insulin dynamic measures at baseline and at follow-up were evaluated using
Spearman correlation coefficient as a nonparametric measure of association based on the rank
order of the S I , Fasting Insulin, AIR and DI values. Similarly, Spearman correlation coefficient
was used to examine the associations between the log-transformed insulin dynamic measures
at baseline and with the measures at follow-up.
Mixed effects models were created to examine the adjusted associations of weight and the
insulin dynamic measure during the baseline and follow-up periods. The random effects
included random intercepts and random slopes at the individual level and random intercepts at
the clinic level. The fixed effects adjusted for baseline age, sex, race/ethnicity, baseline BMI and
time-dependent diabetes status. S I , fasting Insulin, AIR and DI were included separately in each
model and were scaled to have unit variance. This analysis explained how weight coevolves
with the insulin measures of interest.
In addition, this study analyzed a cross-sectional and prospective relationship between weight
change and the insulin dynamic measures. In these models, time was presented as number of
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months between the baseline and follow-up visits, whereas age at baseline was used as an
adjustment variable. The insulin variables were presented as baseline value and change
between follow-up and baseline. Interaction term between time and the baseline insulin
measure presented a prospective relationship. We report three parameters for each insulinrelated measure adjusted by age, sex, ethnicity, baseline BMI and time-dependent diabetes
status: beta-coefficient for baseline variable presents cross-sectional association with weight at
baseline, beta-coefficient for the interaction term between baseline values and time presents a
prospective association between baseline and weight at follow-up, and beta-coefficient for
change variable shows associations between change in the variable and weight during the
follow-up period. The beta-coefficient and standard error values were scaled by the standard
deviations of the corresponding predictors. These models answered the question of whether
the dynamic measure of interest can be causal in relation to weight change.
IV. Results
Descriptive characteristics of the study population by weight change status (≥5% Increased
Weight, <> 5% No Weight Change, and ≤5% Decreased Weight) are shown in Table 1. At the
follow-up visit, 31% of the participants had increased weight, 58% had little weight change, and
12% had decreased weight. There was a significant difference in the proportions of females
across weight groups: 61% females/39% males increased weight, 53% females/48% males had
little weight change, and 66% females/34% males decreased weight (p<0.008). The results
suggest BMI at baseline was significantly associated with weight change: participants with
greater BMI were more likely to change weight in either direction whereas participants with
lower BMI tended to have little weight change (p<0.02). Race/ethnicity was not associated with
weight change. Participants with normal glucose tolerance (NGT) at baseline showed a greater
tendency to increased weight (p=0.06).The overall test for the association between glucose
tolerance/diabetes status and weight change showed no association, participants who
developed diabetes also had a tendency to increase weight. Insulin sensitivity at baseline was
similar among all three weight-change groups. During the follow-up, S I decreases on average at
follow-up with the greatest change among those who gained weight (-1.1 mean difference) as
compared to participants with stable weight (-0.8 mean difference) and a no change among
those with weight decrease p<0.001). As expected, relationship with Fasting insulin mirror
those with S I : participants with Increased Weight experienced the greatest increase in fasting
insulin (+6.4 mean change) as compared to participants with No Weight Change( +2.5 mean
change), whereas participants with Decreased Weight showed no meaningful changes in fasting
insulin (p<0.001). Baseline acute insulin response showed a tendency toward inverse
association with weight change with the greatest values among those who gained weight and
lowest among those who lost weight (p=0.2). In all three weight change groups, AIR increased
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over time (Increased Weight + 23.4 mean difference, No Weight Change +16.7 mean difference,
Decreased Weight +2.7 mean difference) and these changes amplified the differences at the
follow-up (p<0.001). Disposition Index at baseline showed a clear tendency of inverse
association with weight change with the greatest values among those who gained weight and
lowest among those who lost weight (p<0.01). However, the changes in DI were different
among the three groups: participants with increased weight experienced the greatest drop in DI
followed by those with relatively stable weight, whereas those who lost weight showed
increase in DI at follow-up. The opposite tendencies in DI change between the weight loss and
weight gain groups narrowed the gap in DI at follow-up as compared to baseline (p value for
the difference between the groups at follow-up = 0.1).
Table 1. Characteristics of study population by weight change status
N=879
Increased Weight
No Weight Change
(≥5%) n=268
(<> 5%) n=510
Age (years)
52.3±8.2
55.7±8.3
Male (%)
104 (39)
242 (47.5)
Female (%)
164 (61)
268 (52.6)
Ethnicity
White
106 (39.6)
205 (40.2)
African American
79 (29.5)
125 (24.5)
Hispanic
83 (31)
180 (35.3)
BMI (kg/m2) at baseline
28.6±5.8
27.9±5.3
Glucose Tolerance (Diabetes
Status) at baseline
Normal
189 (72.5)
342 (67.1)
Impaired
79 (29.5)
168 (33)
Glucose Tolerance (Diabetes
Status) at follow-up
Normal
140 (52.2)
301 (59)
Impaired
80 (29.9)
128 (25.1)
Diabetic
48 (17.9)
81 (15.9)
Insulin Sensitivity (S I )
(S I , x10-4minutes-1/µUml)
at baseline
2.2±1.9
2.2±1.9
Insulin Sensitivity (S I )
(S I , x10-4minutes-1/µUml)
at follow-up
1.1±1.4
1.4±1.4
Fasting Insulin (uU/mL)
at baseline
15.0±10.9
15.8±17.4
Fasting Insulin (uU/mL)
at follow-up
21.4±13.7
18.3±13.2
Acute Insulin Response (AIR)
(µU/ml X minutes)
at baseline
68.8±51.6
65.0±61.2

Decreased Weight
(≤5%) n=101
55.6±8.9
34 (33.7)
67 (66.3)
41 (40.6)
31 (30.7)
29 (28.7)
29.5 (5.3)
58 (57.4)
43 (42.6)
55 (54.5)
31 (30.7)
15 (14.9)

P
<0.001
0.008
0.008
0.4

0.02
0.06

0.4

1.9±1.6

0.2

1.9±1.4

<0.001

16.2±9.5

0.3

16.1±9.1

<0.001

59.4±44.4

0.2
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92.2±72.3

81.7±79.0

62.1±44.8

<0.001

131.2±125.4

111.1±112.9

93.7±92.0

<0.001

91.0±103.3

96.9±110.9

97.3±82.6

0.1

Data are n (%) and means ± SD. Categorical variables and age were assessed using Chi-square test. Continuous
variables were assessed using Kruskal-Wallis test. AIR is the mean of 2,4 minute insulin injection.

To assess the association between the insulin dynamic measures at baseline, Spearman
correlation coefficient test was used to rank-order pairs of S I , fasting insulin, AIR and DI as
shown in Table 2. As expected, there is a strong inverse association between fasting insulin and
S I (r = -0.66, p<0.001). Fasting insulin was positively correlated with AIR (r = 0.33, p<0.001) and
negatively correlated with DI (r = -0.10, p<0.005). AIR was correlated with S I (r = -0.30,
p<0.001). Strongly associated AIR and DI is determined by the mathematical relationship
between AIR and DI. DI was also correlated with S I (r = 0.34, p<0.001).
Table 2. Correlation between insulin dynamic measures at baseline
N=879
Log Insulin
Log Fasting
Log Acute Insulin
Sensitivity
Insulin
Response
Log Insulin Sensitivity
Spearman Corr.
Sig. (2-tailed)
N
Log Fasting Insulin
Spearman Corr.
Sig. (2-tailed)
N
Log Acute Insulin
Response
Spearman Corr.
Sig. (2-tailed)
N

Log
Disposition
Index

.
.
.

-0.66
<.0001
817

-0.30
<.0001
818

0.34
<.0001
818

-0.66
<.0001
817

.
.
.

0.33
<.0001
840

-0.10
0.005
817

-0.30
<.0001
818

0.33
<.0001
840

.
.
.

0.76
<.0001
818

Spearman correlation coefficient rho [r], Prob >[r]. Log-transformed S I , fasting insulin, AIR and DI.
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Next, the association of insulin dynamic measures between baseline and follow-up periods are
shown in Table 3 to assess the correlation of the insulin variables between visits. As expected
all predictors at baseline have high correlation with the follow-up period. Similar to Table 2, the
correlations remain significant with the exception of the correlation between baseline DI and
fasting insulin at follow-up which changes to not significant (r = -0.06, p = 0.11). Fasting insulin
and S I are inversely correlated which was also found in previous studies examining the IRAS
cohort (26, 35).
Table 3. Correlation of insulin dynamic measures between baseline and at follow-up
N=879
Log Insulin
Log Fasting
Log Acute Insulin
Sensitivity
Insulin
Response
Follow-up
Follow-up
Follow-up
Log Insulin Sensitivity
baseline
-0.56
-0.11
Spearman Corr. 0.64
<.0001
0.002
Sig. (2-tailed) <.0001
813
756
N 737
Log Fasting Insulin
Baseline
Spearman Corr. -0.51
0.60
0.14
Sig. (2-tailed) <.0001
<.0001
<.0001
N 780
872
802
Log Acute Insulin Response
Baseline
Spearman Corr.
Sig. (2-tailed) -0.20
0.31
0.69
N <.0001
<.0001
<.0001
759
836
778
Log Disposition Index
Baseline
Spearman Corr. 0.22
-0.06
0.61
Sig. (2-tailed) <.0001
0.11
<.0001
N 737
813
756

Log Disposition
Index
Follow-up

0.22
<.0001
736

-0.12
0.0006
779

0.53
<.0001
758

0.69
<.0001
736

Spearman correlation coefficient rho [r], Prob >[r]. Log-transformed S I , fasting insulin, AIR and DI.

The next analysis used a mixed-effects model approach to examine S I , fasting insulin, AIR, DI
that predicted weight. Table 4 shows time-dependent relationships between each insulin
dynamic measure and weight during the follow-up period adjusting for baseline age, sex,
race/ethnicity, central adiposity (baseline BMI) and glucose tolerance (diabetes status). The
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strongest associations with weight in time were found for the variables related with insulin
resistance. S I shows an inverse association with weight in time: β = -0.91, 95% CI=(-1.27,-0.56),
and fasting insulin positively correlates with weight β = 0.96, 95% CI=(0.64, 1.27). Response of
the pancreases to glucose challenge showed weaker relationships with weight in time: AIR
positively correlates with weight β = 0.38, 95% CI=(0.05, 0.73) and there is a weak tendency for
inverse relationship between DI and weight.
Table 4. Weight and insulin dynamics during the follow-up period adjusted for age, sex, race/ethnicity,
baseline BMI, and diabetes status and clinic included as a cluster variable
Beta-coefficient (SE)
95% CI
P-value
Log S I
-0.91 (0.18)
-1.27, -0.56
<.0001
Log Fasting insulin

0.96 (0.16)

0.64, 1.27

<.0001

Log AIR

0.38 (0.17)

0.05, 0.73

0.02

Log DI

-0.22 (0.18)

-0.56, -0.13

0.22

Beta-coefficient and standard error values are scaled to one standard deviation.

In Table 5, the relationships between each insulin dynamic predictor and weight is presented in
three ways – cross-sectional association at baseline, association with change in the insulin
measures, and a prospective association between baseline insulin measures and weight at the
end of follow-up. This approach did not reveal any meaningful cross-sectional associations
between insulin measures and weight at baseline. The strongest relationships were found
between changes in the examined insulin measures and weight. Baseline values predicted
weight change in a similar direction (except DI), but these associations were weaker. This
approach showed that the change in S I was inversely associated with weight: β = -2.43, 95%
CI=(-2.99, -1.87). Also, greater insulin sensitivity at baseline predicted loss of weight when time
elapsed for a long duration (t>0.123, β = -0.17, 95% CI=(-0.27,-0.08). Increase in fasting insulin
implied weight gain: β = 2.10, 95% CI= (1.61, 2.60). Greater baseline fasting insulin also
predicted increase of weight: β = 0.13, 95% CI=(0.04, 0.22). Similarly, increase in AIR had a
positive association with weight: β = 1.11, 95% CI=(0.67, 1.55). Baseline AIR predicted weight
gain: β = 0.11, 95% CI=(0.03, 0.19). DI did not show strong relationships with weight in this
model.
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Table 5. Associations of weight with baseline and change of insulin-related variables adjusted for age,
sex, race/ethnicity, baseline BMI, and diabetes status and clinic included as a cluster variable
Beta-coefficient scaled to SD
Cross-sectional Assoc.
Association with Change
Prospective Association
Log SI
β (SE) 0.30 (0.25)
-2.43 (0.28)
- 0.17 (0.05)
95% CI -0.19, 0.80
-2.99, - 1.87
-0.27, -0.08
P 0.23
<.0001
0.0002
Log Fasting
insulin
2.10 (0.25)
0.13 (0.04)
β (SE) 0.001 (0.24)
1.61, 2.60
0.04, 0.22
95% CI -0.46, 0.47
<.0001
0.003
P 1.00
Log AIR
β (SE)
95% CI
P
Log DI
β (SE)
95% CI
P

-0.02 (0.22)
-0.46, 0.41
0.91

.
1.11 (0.22)
0.67, 1.55
<.0001

0.11 (0.04)
0.03, 0.19
0.008

0.10 (0.23)
-0.35, 0.55
0.66

-0.48 (0.29)
-1.05, - 0.08
0.09

0.06 (0.05)
-0.03, 0.15
0.18

Beta-coefficient and standard error values are scaled to one standard deviation.

V. Discussion and Conclusion
The aim of this study was to investigate the insulin dynamic factors: insulin sensitivity (S I ),
fasting insulin, acute insulin response (AIR), and disposition index (DI) associated with weight
change in a cohort of multiethnic participants. The hyperbolic law of glucose tolerance states
that DI should remain constant as long as changes in the insulin action are compensated for by
the changes in insulin secretion to maintain glucose homeostasis (1, 36). Although it is possible
that one of the insulin measures would play a dominant role, the pathways that determine
observed levels of these metabolic predictors are interdependent as a function of biologic
feedback systems (26, 37). We hypothesized that insulin resistance measures will increase but
the insulin secretion measures will decrease with weight gain as the body compensates for
energy imbalance.
Our study showed that all insulin dynamic measures are interrelated. Fasting insulin and AIR
increase to compensate for lower insulin sensitivity, whereas DI shows pancreatic beta-cell
function with the offset for insulin resistance (Tables 2 & 3). The crude associations show that
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greater insulin secretion (AIR and DI) at baseline predict a risk of weight gain. However, weight
gain leads to a decline in beta-cell function and therefore a decrease in DI (Table 1), whereas
weight loss improves beta-cell function leading to an increase in DI (Table1). As insulin
resistance is known to be associated with weight gain, time-dependent associations of weight
with insulin measures show an inverse association with S I and positive association with fasting
insulin. Weight increase was also associated with insulin secretion probably as a compensation
for increased insulin resistance (Table 4). When insulin measures were presented as baseline
values, changes and the interaction between baseline and time, the cross-sectional associations
were not important. Their change was mainly associated with weight dynamics and the baseline
values showed associations with weight at follow-up in the expected direction. These results
imply that insulin measures are mostly a consequence of weight change (strong correlation
with change) and to a lesser degree a cause of weight changes (interaction between baseline
and time).
A strength of this study design as identified in the review article by Chiu et al. was that few
recent studies have examined weight as an outcome variable and also include laboratory tests
to evaluate the insulin dynamic variables (17). Additionally, the study population was a large
sample with even representation of men and women from a diverse race/ethnic background
which were followed for a 5 year period. Few current studies have a large sample size or ethnic
diversity. The statistical approach provided analysis of the insulin parameter of interest at
baseline, and the change in value over time related to predicting weight change.
Although the range of laboratory tests and anthropometric measures were comprehensive in
this study, selection of participants for a clinical study may reflect a different variability than the
general population.
Future directions for research could investigate the diabetic status of individuals and
relationship with weight change. Participants with impaired glucose status may have different
associations than what we found in the current study. A better understanding of insulin
dynamics may lead to earlier diagnosis of an imbalanced metabolic state and provide additional
prevention programs to reduce morbidity associated with any negative impact of weight
change.
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